Clinical Trials · NCT03548935
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,961
- Start date
- Jun 2018
- Locations
- 128 sites, 17 countries
- Primary endpoint
- Change in Body Weight (%)